Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Gold ETFs Break 13-Month Win Streak As Investors Pull Out Rs 725 Crore In May
Net gold ETF outflows stood at Rs 725 crore, according to data released by the Association of Mutual Funds in India
Nifty above 23,300 level; FMCG shares in demand
At 10:30 IST, the barometer index, the S&P BSE Sensex, jumped 288.00 points or 0.39% to 74,208.58. The Nifty 50 index rose 74.90 points or 0.32% to 23,314.45.
India equity mutual fund inflows slip to one-year low in May amid Iran war jitters, AMFI data - Reuters
India equity mutual fund inflows slip to one-year low in May amid Iran war jitters, AMFI dataReuters
Hindustan Zinc Ltd Slides 2.79%
Hindustan Zinc Ltd has lost 12.86% over last one month compared to 0.29% fall in BSE Metal index and 2.67% drop in the SENSEX
Bharti Hexacom Ltd Surges 1.19%
Bharti Hexacom Ltd has added 1.89% over last one month compared to 0.07% gain in BSE Teck index and 2.67% drop in the SENSEX
Indices edge higher in early trade; breadth positive
At 09:30 IST, the barometer index, the S&P BSE Sensex, jumped 365.97 points or 0.50% to 74,272.54. The Nifty 50 index rose 90.30 points or 0.39% to 23,329.70.
Stock Market Live Updates Today: BSE Sensex, Nifty50 may see volatile session as crude oil prices rise on fresh US-Iran tensions - The Times of India
Stock Market Live Updates Today: BSE Sensex, Nifty50 may see volatile session as crude oil prices rise on fresh US-Iran tensionsThe Times of India

Jio BlackRock prepares ETF debut by August after building $2 billion India fund base By Reuters - Investing.com
Jio BlackRock prepares ETF debut by August after building $2 billion India fund base By ReutersInvesting.com
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment

Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.